Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Norvium Bioscience Drug Patent Portfolio

Norvium Bioscience owns 1 orange book drug protected by 2 US patents Given below is the list of Norvium Bioscience's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7141237 Pharmaceutical foam 03 Feb, 2024 Expired
US7374747 Pharmaceutical foam 23 Jan, 2024 Expired


Given below is the list of recent legal activities going on the following drug patents of Norvium Bioscience.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 22 Oct, 2019 US7374747
Payment of Maintenance Fee, 12th Year, Large Entity 13 Apr, 2018 US7141237
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 17 Jan, 2012 US7374747
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 29 Jul, 2010 US7141237
Correspondence Address Change
Critical
11 Sep, 2009 US7141237
Correspondence Address Change
Critical
11 Sep, 2009 US7374747
Recordation of Patent Grant Mailed
Critical
20 May, 2008 US7374747
Patent Issue Date Used in PTA Calculation
Critical
20 May, 2008 US7374747
Issue Notification Mailed
Critical
30 Apr, 2008 US7374747
Application Is Considered Ready for Issue
Critical
04 Apr, 2008 US7374747
Dispatch to FDC 04 Apr, 2008 US7374747
Issue Fee Payment Verified
Critical
21 Feb, 2008 US7374747
Issue Fee Payment Received
Critical
21 Feb, 2008 US7374747
Mail Examiner Interview Summary (PTOL - 413) 05 Feb, 2008 US7374747
Mail Examiner's Amendment 05 Feb, 2008 US7374747


Norvium Bioscience's Family Patents

Norvium Bioscience drugs have patent protection in a total of 15 countries. It's US patent count contributes only to 25.8% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Norvium Bioscience Drug List

Given below is the complete list of Norvium Bioscience's drugs and the patents protecting them.


1. Evoclin

Evoclin is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7141237 Pharmaceutical foam 03 Feb, 2024
(1 year, 7 months ago)
Expired
US7374747 Pharmaceutical foam 23 Jan, 2024
(1 year, 7 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Evoclin's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List